These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 6153937

  • 1. Lung damage from cytotoxic drugs.
    Collis CH.
    Cancer Chemother Pharmacol; 1980; 4(1):17-27. PubMed ID: 6153937
    [Abstract] [Full Text] [Related]

  • 2. Cytotoxic drug-induced pulmonary disease: update 1980.
    Weiss RB, Muggia FM.
    Am J Med; 1980 Feb; 68(2):259-66. PubMed ID: 6153504
    [Abstract] [Full Text] [Related]

  • 3. Pulmonary effects of cytotoxic agents other than bleomycin.
    Twohig KJ, Matthay RA.
    Clin Chest Med; 1990 Mar; 11(1):31-54. PubMed ID: 1691069
    [Abstract] [Full Text] [Related]

  • 4. Cytotoxic drug-induced lung disease.
    Sostman HD, Matthay RA, Putman CE.
    Am J Med; 1977 Apr; 62(4):608-15. PubMed ID: 66869
    [Abstract] [Full Text] [Related]

  • 5. Hepatic and pancreatic damage produced by cytotoxic drugs.
    Woolley PV.
    Cancer Treat Rev; 1983 Jun; 10(2):117-37. PubMed ID: 6223696
    [No Abstract] [Full Text] [Related]

  • 6. Immunosuppressive and cytotoxic chemotherapy: long-term complications.
    Schein PS, Winokur SH.
    Ann Intern Med; 1975 Jan; 82(1):84-95. PubMed ID: 67817
    [Abstract] [Full Text] [Related]

  • 7. [Pulmonary toxicity of antineoplastic agents--with special reference to current findings on pulmonary toxicity of bleomycin].
    Okuma K, Ota K.
    Gan To Kagaku Ryoho; 1982 Sep; 9(9):1495-505. PubMed ID: 6191717
    [Abstract] [Full Text] [Related]

  • 8. Drug reactions. XXIV. Cutaneous reactions to cytostatic agents.
    Levantine A, Almeyda J.
    Br J Dermatol; 1974 Feb; 90(2):239-42. PubMed ID: 4132051
    [No Abstract] [Full Text] [Related]

  • 9. Pulmonary toxicity of antineoplastic agents: anaesthetic and postoperative implications.
    Klein DS, Wilds PR.
    Can Anaesth Soc J; 1983 Jul; 30(4):399-405. PubMed ID: 6347353
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Hair changes in immunosuppressive therapy].
    Kostanecki W, Mazurkiewicz W, Górkiewicz A, Zborzil J.
    Z Haut Geschlechtskr; 1971 Oct; 46(19):704-8. PubMed ID: 5137252
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Teratogenicity from drugs--an increasing problem.
    Shepard TH.
    Dis Mon; 1974 Jun; ():1-32. PubMed ID: 4494537
    [No Abstract] [Full Text] [Related]

  • 16. Ambroxol and pulmonary toxicity induced by antineoplastic drugs.
    Luisetti M, Peona V, Salmona M, Pagnoni AM, Villani F, Knerich R, Genghini M, Abbà L, Pozzi E.
    Int J Clin Pharmacol Res; 1986 Jun; 6(2):129-36. PubMed ID: 2424848
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The problem of permanent bone marrow damage after cytotoxic drug treatment.
    Lohrmann HP.
    Oncology; 1984 Jun; 41(3):180-4. PubMed ID: 6374556
    [Abstract] [Full Text] [Related]

  • 19. The spectrum of drug-induced pulmonary disease.
    Rosenow EC.
    Ann Intern Med; 1972 Dec; 77(6):977-91. PubMed ID: 4118760
    [No Abstract] [Full Text] [Related]

  • 20. [Pulmonary fibrosis following treatment with cytostatics].
    Kühböck S.
    Wien Med Wochenschr; 1976 Oct 01; 126(40):568-70. PubMed ID: 62459
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.